Abstract. Diabetes mellitus (DM) and mental health problems are frequently co-occurring conditions. Anxiety and depressive disorders are the most common mental disorders that accompany DM. These conditions could have severe consequences in children and adolescents suffering from DM. Thus, it is important to pay additional attention to them. This article provides an overview of prevalence rates of DM and co-occurring anxiety and depression, as well as understanding the etiology and treatment options for anxiety and depressive disorders in children and adolescents with DM.
INTRODUCTION
Diabetes mellitus (DM) is a metabolic disease originating due to insulin secretion defects, insulin action defects, or both 1 . There are three main types of diabetes: Type 1 diabetes (T1D), Type 2 diabetes (T2D) and Gestational diabetes 2 . T2D is the most common type of DM, which usually affects adults, but is also prevalent in paediatric population 2 . Reliable data concerning epidemiological rates are scarce, but it appears that T2D in childhood could soon become a global public health issue 2 . T1D can originate in any age, but its onset is usually in childhood or young adulthood 2 . Moreover, T1D is one of the most common endocrine and metabolic conditions in childhood, with the number of children diagnosed increasing every year 2 . The International Federation of Diabetes (IFD) estimated that the number of children younger than 15 affected by T1D in 2015 was about 542 000, with an estimated increase around 3 % per year and with 86 000 newly diagnosed cases per year (the highest incidence rates being in Finland, Sweden and Kuwait) 2 .
MENTAL HEALTH PROBLEMS AND DM
Mental health problems and T1D are frequently co-occurring conditions throughout childhood and adolescence. Current reports record a comorbidity rate of mental health disorders at about 20 to 50 % in children and adolescents suffering from DM 3 . It is important to state that not all studies report a significant increase in psychopathology in patients with DM 3 , albeit the risk does tend to be greater in diabetes suffering, compared to healthy children and adolescents 4 . Considerable evidence of an association between psychological disorders and juvenile diabetes is nowadays present 5 . In addition, studies show that adolescents with DM tend to have more severe internalizing symptoms, as opposed to healthy adolescents 6 . Mood disorders are the most frequent co-occurring diagnosis in youth with T1D 6 , whereas the most frequent mental health problems in youth with DM are depression followed by anxiety 5 ; characterized by different emotional, cognitive, and behavioral changes that affect the individual's quality of life and capacity for everyday functioning. As a group of different conditions, anxiety disorders are characterized by excessive fear and anxiety, whilst depressive disorders are characterized by the presence of sad, empty, or irritable mood 7 . Although anxiety and depression seem to have an important role in determining adaptation to the disease, their relationship to metabolic control still isn't clear 5 . Specifically, studies show that depression in youth has been associated with relSymptoms of anxiety and depressive disorders frequently co-occur with paediatric diabetes mellitus (DM) and seem to be associated with significant medical complications, poor treatment adherence, and consequently impaired quality of life. Various biological, psychological, and environmental links are implicated in the relationship between anxiety and depressive symptoms and DM.
evant outcomes regarding the treatment of T1D, such as adherence to DM regimen in glucose monitoring and poorer metabolic control 8 . In some studies, depression was associated to poorer insulin injection and dieting 9, 10 , as well as psychological outcomes such as poor quality of life 11 and low self-esteem 9, 12 . Studies show that 20 % of metabolic control variance could be explained by depressive symptoms and that these children have lesser glycaemic control 13 . Moreover, there seems to be an increase in suicidal ideation in adolescents with T1D 14 . It is necessary to understand the relationship between DM, anxiety and depressive symptoms in children and adolescents in order to prevent developing potentially serious outcomes that can arise from this comorbidity. Thus, this article provides an overview of prevalence rates of DM and co-anxiety and depressive disorders, as well as understanding the etiology and treatment options.
PREVALENCE RATES OF ANXIETY AND DEPRESSIVE SYMPTOMS IN DM
Anxiety and depressive symptoms in children and adolescents with T1D tend to appear more often 8, 15 . A study conducted by Kokkonen and Kokkonen 16 found only a moderate prevalence of depression in children and adolescents. Nevertheless, they concluded that DM in childhood itself could not be considered a risk factor for mental health in young adulthood. The disease could only strengthen the severity of psychological symptoms, especially depression, which seems to be a severe affective disorder when co-occurring with DM 16 . Follow-up longitudinal studies made by Kovacs and colleagues 17 found that the first year of T1D is associated with highest incidence of psychiatric disorders in general, but with anxiety and depressive disorders in particular. In a ten year-span, more than two out of five children suffering from DM experienced one episode of mental health disorders, whereas one out of four developed depression 17 . Whereas mental health problems seem to prevail quite often throughout a ten-year span, there also seems to be an initial increase of depressive symptoms after DM diagnosis. Grey, Whittemore and Tamborlane   8 found that children with DM reported significantly greater levels of depressive distress at the time of DM diagnosis and at the end of a second year follow-up, compared to children without DM. They also found a prevalence of depressive symptoms affecting up to every fifth adolescent with T1D registered in clinical settings 8 . Furthermore, they found that the duration of DM significantly correlated with depressive symptoms in a U-shaped manner. In other words, earlier post diagnosis years and ten-year duration of T1D was associated to more depressive symptoms, whereas in the period between four to nine years post diagnosis depressive symptoms were less common 8 . A meta-analytic report, which included 22 studies, indicated that children suffering from DM, compared to peers, experience elevated levels of depression, anxiety and psychological distress, although the effect was found to be small to medium 18 . Furthermore, it showed that children with poor metabolic control amongst DM patients manifest larger anxiety and psychosocial distress, meaning that poorer control of the disease could lead to mental problems 18 . Another systematic review and meta-analysis 19 , which included 14 studies, showed that the occurrence of anxiety symptoms is raising up to every third child and adolescent suffering from T1D. Herzer and colleagues 20 also reported a correlation between the onset of depression and anxiety in patients with DM, meaning that they tend to appear conjointly. Given the vast prevalence and potential severity of mental health comorbidities, mental screening is a procedure advised to become a basic part of clinical practice standards in children and adolescents with DM, in addition to medical examination and treatment 4, 21 .
FACTORS RELATED TO DEVELOPMENT OF ANXIETY AND DEPRESSIVE SYMPTOMS
Risk factors that increase the likelihood of depression and anxiety among children and adolescents suffering from DM are many, and are conceptualized as negative experiences, demographic variables, environmental characteristics and biological mechanisms. Below we give an overview of the factors most commonly reported in literature.
DM as a stressful life experience
DM itself, especially T1D, is considered to be a stressful life experience and could cause significant depressive symptoms 8 . Nevertheless, even if DM is shown to be a risk factor for depression onset 18 , the relationship could be bidirectional, since it is possible for mental health problems to also cause poorer metabolic control 22, 23 . A few authors state that DM is not a risk factor for depression, although it can strengthen the severity of psychological symptoms 19 . The nature of the relationship between DM and mental problems remains unclear, and more research determining causal relationships is needed. Aside from mental health problems, studies show that children with T1D are also at high risk for developing behavioural problems 24, 25 . Young adults with DM are often viewed as different and stigmatized, and, in the age they find themselves in, such discrimination from their peers and consequent stressful experiences can lead to negative well-being 26 . Adolescents suffering from T1D, 12 to 15 year-olds, were found to experience more social anxiety symptoms than healthy adolescents 27 , since it is possible that peer evaluation and support are somewhat jeopardized by the disease itself, and the participation in social activities is scarce.
Negative (self-) evaluation
Young adults suffering from DM tend to evaluate negatively their competence regarding self-care 28 .
Various experiences, such as negative evaluation and self-feedback could create a negative feedback loop, which increases the likelihood of anxiety and depressive disorders in DM 28 . Negative interpretation of events and self-competence could therefore lead to mental health problems. Negative experiences and symptoms could interact and lead to a worsening in mental health, and therefore increase the likelihood of depression and anxiety onset in paediatric DM, a hypothesis that needs to be further examined.
Age and gender
Adolescents are more prone to depression than children, since it is a period of rapid change 8, 29 . Gender, especially in the period of adolescence, is also a factor. Girls are more prone to and manifest depression symptoms 30 , in respect to boys, although the evidence is still contradictory 8 . Research suggests that girls tend to report more anxiety, depression and internal distress symptoms 10 . This could be a consequence of different responses to life stressors commonly experienced in adolescence, not DM exclusively. Girls tend to internalize stress, which can lead to more dysphoric feelings 10 . It also seems that gender differences tend to enhance during adolescence, with coping strategies such as rumination leading to enhanced depressive symptoms in girls, compared to boys 31 , in respect to childhood.
Family environment
The family context is a very important factor in understanding how children adjust to a chronic illness and cope with it. A cohesive family environment can benefit a child's well-being, with parents being supportive and flexible about their child's needs 32 . Studies show that lack of parenting skills and family conflict can lead to internalizing disorders in adolescents 3 . The family environment following DM diagnosis, especially T1D, can become emotionally charged and result in conflict among family members, which can lead to psychological distress, such as anxiety and depressive disorders in children 13, 20, 33 . In the presence of "diabetes-specific family conflict", anxiety seems to be triggered or heightened, leading to poor glycaemic control via diabetes-related behaviour such as dieting, exercising, etc 20 . Studies show that family dynamics change after the diagnosis of T1D, leading to problems described earlier, since DM tends to influence the family's well-being 34 .
Parenting type
Adolescence is a turbulent developmental phase, with development tasks such as growing autonomy and independency 28 . It is the same with DM maintenance and the independence the child gradually grows in health behaviours themselves. Parents' role is to be supportive of the adolescent and maintain a level of involvement that allows the child to become more independent, but also making certain that medical requirements are present 33, 35 . Over-controlling parenting is related to depressive outcomes in children with DM 35 . On the other hand, supportive parenting with a moderate level of firm control is related to a range of positive child outcomes 35, 36 , better glycaemic control and fewer depressive symptoms 37 . Furthermore, research done on mothers of children with DM found a significant increase in mothers' manifestation of anxious and depressive symptoms 37 . Such maternal symptoms of distress are further shown to be related to over-involved parenting, which can lead to worsening of an adolescent's well-being 35 . Consequently, higher levels of maternal control tend to relate to higher depressive symptoms in female diabetic adolescents, which accounts for gender differences in the outcomes of parenting control 35, 38 . It is therefore indicative that psychological control in parenting could be a risk factor for depressed mood amongst chronically ill adolescents 39 , whereas acceptance could be a protective factor for mental disorders 35 . Firm control, which is perceived as unwanted interference in periods of autonomy development, is also a factor that may contribute to the increase of depressive symptoms, but it appears to occur amongst older adolescents 35, 40 . Amongst younger adolescents, firm http://hrcak.srce.hr/medicina 35, 40 .
Parental mental health
In general, evidence suggests that there is also a strong relationship between mothers and children's depressive symptoms in school-aged children 41 , with mothers' depression being a major risk factor in children's depression 24 . Mothers with higher level of depressive symptoms tend to provide lesser support and warmth, potentially leading to lower psychosocial adjustment of the child and adolescent 41, 42 . Paternal and maternal stress is also related to depressive symptoms in adolescents with T1D 43 .
Biological mechanisms
Although many studies address the pathophysiological relationship between the onset of DM and depression, mechanisms by which depression and DM relate to each other are still to be established 44 . There are evidence that glutamic acid decarboxylase autoantibodies (GADA), which are related to DM, could influence the synthesis of the gamma-aminobutyric acid (GABA), which in return is shown to be associated to depressive symptoms and cognitive dysfunction 45 . The link between depression and DM can also have biological connections such as dyslipidaemia, which seems to be a biological correlate of depression and DM in adolescents 19 . There is preliminary evidence that higher levels of depression are associated with metabolic abnormalities and systemic inflammation 46 . T1D may contribute to emotional and biological disruptions, so that depression exacerbates dyslipidaemia 46 . It is also assumed that depression itself is a moderate risk factor for developing DM in young adults, either directly or indirectly [47] [48] [49] . Irving and colleagues 47 explained other biological mechanisms. For one, it is shown that genetic predisposition for T2D can predict levels of depressive symptoms. High depressive symptom scores of children with a familial history of DM have also been noted. One possible explanation is that the duration of generational history of DM might have provided chronic ongoing stress, which may have manifested as depressive symptoms. Another mechanism proposed is the connection between depression and the hypothalamopituitary adrenal axis 47 . Specifically, depression tends to affect the hypothalamopituitary adrenal axis, which can lead to elevated glucose levels and decreased glucose uptake, leading to manifestation of T2D.
ADHERENCE TO TREATMENT
Problems with non-adherence are a common difficulty in DM that can potentially lead to severe medical complication outcomes 8, 50 . Adolescents with T1D tend to demonstrate poor diabetes management behaviour, making them a risk group for unhealthy outcomes regarding DM 20 . Depressive symptoms in adolescents with DM are associated to poor adherence to treatment 8 , often leading to scarce metabolic control 22 , as well as higher levels of HbA1c 23 . Regarding that, psychosocial factors of DM described earlier could be one of the most influential factors affecting care and treatment of DM in children 21, 50, 51 . Studies differentiate high-risk children from moderate-risk children for negative disease outcomes and the accompanying characteristic behaviour patterns 50 . Higher-risk children are more problematic, since they tend to have a higher incidence of poor coping skills, behaviour problems and a significant delay in developmental phases 50 . High-risked children have a tendency of coping with stress by reacting emotionally, avoiding problems and not seeking help, as well as indulging in undesirable behaviour, leading to poorer adherence to treatment 50 . Thus, one of the factors contributing to non-adherence in adolescents with depression is ineffective response to daily levels of stress, leading to less engagement in health related behaviours and, on the other hand, a possible increase in HbA1c 52 . Moreover, adolescents with depressive symptoms tend to overreact to acute stressors and have little problem-solving abilities, often leading to complications and the reoccurrence of depressive symptoms, which are in turn problematic for long-term DM management 22 . It also appears that depressive reactions to the illness itself can have a significant impact on families of children with DM, as well as an impact on treatment adherence itself 8 . Concerning the latter, studies show that depression in DM is associated to high- 54, 55 . Poor adherence to the tasks required for self-management can consequently lead to a suboptimal glycaemic control, with diabetic control decaying throughout the years, being lowest at ages 18-19 54, 56 . Nevertheless, general individual differences in adherence to treatment exist 57 . One of the factors that might contribute to differences in medical behaviour is illness representation 57 . Illness representation is a term conceptualizing a common sense belief about the illness itself, with four attributes in the background: identity (reported illness symptoms), cause (perceived biological, emotional, environmental and psychological factors that lead to the disease), consequence (beliefs regarding the impact of the illness on the patient's life), and control (beliefs about control of the illness and treatment control) 57 . Self-management is considered to be a coping strategy for one's illness, with consequence and control being major predictors of adherence to DM regimen and treatment 54, 58 . Furthermore, negative illness representation is shown to predict more anxiety and depression symptoms among adolescents with DM 59 . Additionally, fear of negative evaluation and lack of family support are considered as potential predictors of psychological maladjustment 59 . Fear of negative peer evaluation, especially in the context of visible physical symptoms of DM -such as shaking and fatiguecould lead to anxiety 59 . Moreover, adolescents who perceive DM they are suffering from as having major consequences, tend to have more intense depressive symptoms, whereas illness identity (symptoms that occur) leads to higher anxiety and depressive symptoms 59 .
TREATMENT OF DEPRESSION AND ANXIETY IN DM

Medication
Various antidepressants, such as fluoxetine, sertraline, citalopram, bupropion or nortriptyline, could be effective in reducing depressive symptoms in adults with DM, with possibly no adverse effects on glycaemic control 60 . Some studies show that reducing depressive symptoms by antidepressants in patients with DM is associated not only with better health behaviour, but also with favourable outcomes in glycaemic control 61, 62 . Although limited, there is evidence on the safety of antidepressants as related to glycaemic control, but when selecting an antidepressant clinicians should consider present diabetic complications and major side effects of different antidepressant groups 63 . A general recommendation for adult patients is to use fluoxetine or sertraline for depression in DM suffering patients 64 . In terms of reducing depressive symptoms and improving functioning amongst children suffering from depression, fluoxetine is probably the best option to consider for pharmacological treatment for children and adolescents 65 , even if there are some safety concerns and there are no valid research studies to base recommendations on. The effectiveness of antidepressants in treating anxiety and depressive disorders in paediatric DM has not been documented. Both fluoxetine and sertraline are part of selective serotonin reuptake inhibitors (SSRI), which are also the most prescribed medications to children and adolescents 66 . In Croatia, among SSRI, sertraline seems to be the most frequently prescribed antidepressant for treating depression in children and adolescents, followed by fluvoxamine, tianeptine and others 66 . Fluvoxamine is also frequently used for the treatment of anxiety disorders in children and adolescents 66 .
Psychotherapy
There is evidence of efficient psychotherapeutic strategies targeting well-being, stress management, and self-management in DM, such as family therapy and self-reliance therapeutic or supportive approaches [67] [68] [69] . These techniques could help overcome different DM care challenges, such as adherence to treatment, mild psychological distress, or diabetic complications. Moreover, Bitsko and colleagues 70 found that psychological intervention (focused on incorporating the family into the care of the child, behavioral aspects of medical management, and cognitive processing) significantly reduced HbA1c over time, leading to better A. Đorić, D. Stevanović, R. Knez: Anxiety and depressive disorders in children and adolescents suffering from diabetes mellitus medicina fluminensis 2018, Vol. 54, No. 2, p. 166-176 metabolic control in patients undergone psychological treatment. A wide palette of psychotherapy methods used in anxiety and depression treatment exists. However, we chose to address those methods whose efficiency has been examined in multiple studies, which specifically address interventions in children and adolescents suffering from DM. Cognitive-Behaviour therapy. One of the widely used psychotherapy methods is Cognitive-Behaviour Therapy (CBT), which is often applied in orself-concept and DM self-efficacy management after CBT treatment. Nevertheless, it failed to demonstrate a significant effect on glycaemic control. On the contrary, Lloyd and Brown 74 found an increased likelihood for remission of depression in patients undergone CBT, compared to the control group, as well as better glycaemic control after CBT treatment, compared to no CBT treatment. Ahmadi and colleagues 75 also found a positive effect of CBT on symptoms of depression and anxiety, as well as better glycaemic control in children 6 to 14 years-old. It seems that learning about negative emotions and their relation to depression could lead to better understanding and better awareness of the condition children and adolescents with DM are coping with. In addition, education about the disease itself and the behaviour that is adequate, could lead to better control of the illness 77 . Shomaker and colleagues 77 found a decrease in depressive symptoms and stabilized insulin sensitivity at one-year follow-up in female adolescents at risk for T2D undergone CBT or health education, explaining that learning to deal with stress could lead to less depressive symptoms and better metabolic control. It is still unclear whether interventions for anxiety and depression influence DM characteristics, such as glycaemic control or others. CBT might be effective in reducing short-term and medium-term glycaemic control, without significant effects for long-term glycaemic control 78 .
Interpersonal therapy (IPT).
IPT focuses on reducing depressive symptoms by improving interpersonal functioning and dealing with interpersonal problems. It relies on focusing on exploration and clarification of feelings, improvement of communication skills, and cognitive-behavioral techniques 79 . Among psychotherapies tested in children and adolescents with co-morbid depression in DM, IPT is shown to be beneficial at posttreatment and at follow-up 80 . Psychosocial interventions. Psychosocial interventions that work individually, such as motivational interviewing, have shown some promising results in improving glycaemic control 81 . In addition, interventions such as coping skills training (CST) appear to have greater effects on adherence and glycaemic control 82 . CST focuses on a Mental health screening and interventions aimed at treating anxiety and depressive disorders in children and adolescents suffering from diabetes mellitus (DM) should be an added approach, in addition to medical treatment of DM. An interdisciplinary approach, with specific individually tailored treatment for patients, and treatment for patients' families, is advised.
der to reduce the negative effect of depression on a patient's well-being 71 . Probably the best option to consider for paediatric depressive symptoms are interpersonal therapy (IPT) or cognitive behavior therapy (CBT) 72 . The basic idea of CBT is that symptoms closely relate to thoughts (cognition), actions and mood. The focus of CBT is to teach patients how to recognize and change maladaptive thoughts, which accompany various disorders, with adaptive ones. It also works on behavioural aspects and directly changes one's behaviour to certain stimulus. Consequently, depressive symptoms, especially in the form of cognitive distortions (a form of maladaptive thoughts), could be reduced 71 . In patients with DM, the same principle applies, since it seems that thought problems could be a discriminant factor of patients with DM and healthy youth, meaning that patients suffering from DM have more thought problems than healthy ones 73 . Studies show that the process undergoing CBT could lead to better glycaemic control, thus consequently indirectly influencing the patient's physical health 74, 75 . A study conducted by Rossello and Jiménez-Chafey 76 showed a significant decrease in depressive and anxious symptoms in patients with DM, as well as an improvement in 83 . Studies show that psychological well-being improves in patients who undergo CST 84 .
Family interventions.
Working with the family of the patient is also of great importance. Since children and adolescents suffering from DM rely greatly on their parent's aid, it could be of importance to work with parents in order to insure the quality of life of both the family and the patient. Interventions such as education about the course of illness and strategies on how to deal with the disease show improvement in metabolic control and better family functioning 84, 85 . Paediatric diabetes care requires supportive and collaborative communication, with realistic expectations for youth 86 . Peer interventions. An important aspect of psychological well-being is also friendship support, since friendship has a protective function for psychological health (both in adolescents with DM and healthy ones) and has implications for physical health among those with DM 87 . Regarding the latter, peer group intervention is also beneficial. Peers are more likely to provide emotional support and companionship in DM care 84 . Involving peers whilst also increasing their knowledge about DM and ways to offer support are effective means in treatment.
Multisystem therapy (MST).
MST, a therapeutic intervention that takes place at home and partly consists of family interventions, is a promising approach in supporting adolescents with T1D. It is a treatment based on social and family system theories of behaviour. Interventions target the adolescent, the family, and the greater community involved in patient care. A Meta -analysis 88 showed that MST is most effective within a population aged up to 15. Ellis and colleagues 89 found a significant increase in adherence after MST. Overall, MST is a rising and promising way to combat adherence issues in youth with T1D 90 .
Treatment recommendation
Due to the lack of clear guidelines, but considering the availability of different medications and psychological interventions for anxiety and depressive disorders, we would recommend the following general principles when dealing with these symptoms in paediatric DM, which are based on the Practice parameters of the American Academy of Child and Adolescent Psychiatry 91, 92 . Psychoeducation, support, and case management are sufficient treatments for the management of uncomplicated or brief depression, mild anxiety or with mild psychosocial impairment in general. In children and adolescents with moderate to severe depression, chronic or recurrent depression, severe anxiety, considerable psychosocial impairment, suicidality, agitation, and psychosis, supportive psychotherapy and case management are usually not adequate. In such cases, more specific types of psychotherapy and/or pharmacological treatment are indicated. Nevertheless, an interdisciplinary approach, including various expert profiles and their collaboration, with specific individualized treatments for patients and their families, is advised as the best DM treatment option 21 .
CONCLUSION
Symptoms of anxiety and depressive disorders frequently co-occur with DM in children and adolescents, and seem to be associated with significant medical complications, poor treatment adherence, and consequently impaired quality of life. The relationship between anxiety and depressive symptoms with DM is still not quite clear, but with various biological, psychological, and environmental links. Mental health screening and interventions aimed at treating anxiety and depressive disorders in children and adolescents suffering from DM should be an added approach, in addition to medical treatment of DM. It is important to state that medical workers, along with the treatment of DM and co-occurring conditions, should also address the overall quality of life in all its aspects. It is important to pay attention to the lifestyle of children suffering from DM. Giving that a chronic disease can affect leisure activities and social activities in a negative manner, it is important that medical interventions occupy a minimum, yet necessary, part of children's daily routine. 
